Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck

Despite significant advances in the use of surgery, chemotherapy and radiotherapy to treat squamous cell carcinoma of the head and neck (SCCHN), prognosis has improved little over the past 30 years. There is a clear need for novel, more effective therapies to prevent relapse, control metastases and...

Descripción completa

Detalles Bibliográficos
Autores principales: Reuter, C W M, Morgan, M A, Eckardt, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360023/
https://www.ncbi.nlm.nih.gov/pubmed/17224925
http://dx.doi.org/10.1038/sj.bjc.6603566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360023/
https://www.ncbi.nlm.nih.gov/pubmed/17224925
http://dx.doi.org/10.1038/sj.bjc.6603566

Ejemplares similares